If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.60    0.60 (0.77%)
Bid:
78.60
Ask:
78.75
Spread: 0.15 (0.191%)
Market Cap: £1.51b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

7 Nov 2025 07:00

RNS Number : 5754G
Coats Group PLC
07 November 2025
 

 

 

 

7 November 2025

Coats Group plc

Full year in line with expectations, resilient trading, good strategic progress

Coats Group plc ('Coats' or the 'Group'), a world-leading Tier 2 supplier of critical components to the apparel and footwear industries, today announces a trading update for the four-month period 1 July to 31 October 2025 ('the period').

 

All the following references are at Constant Exchange Rates (CER) unless specified.

 

Group Performance

 

Market conditions in the period remained subdued, with continued caution in customer ordering patterns as a result of sustained macroeconomic and tariff uncertainty. Against this backdrop, the Group delivered a resilient performance, in line with our expectations.

 

Group revenue in the period was down 1%. We saw encouraging growth in target organic adjacencies as well as further outperformance in core markets. We have also successfully managed pricing pressures and flexed our cost base in the period. As a result operating profit was at a similar level to the same period last year, with margins consistent with H1 2025 and improved from prior year, in line with our Group medium term margin target of 19-21%.

 

Cash generation has remained strong. As anticipated, leverage increased due to the completion of the OrthoLite acquisition at the end of October. We expect year-end leverage to be c.2.2x, consistent with previous guidance, and leverage to fall below 2x by the end of 2026 given the sustained improvement in cash generation.

 

Divisional Performance

 

Apparel

 

Apparel delivered a robust performance in the period with revenue 2% below the prior year period due to challenging end markets. A focus on excellent service and operational agility enabled us to outperform and win share with major brands alongside good growth in China domestic. The division maintained operating margins at c.20% during the period reflecting pricing discipline and favourable mix with customers valuing our premium and sustainable thread offerings.

 

Footwear

 

Footwear revenue was 4% lower than the prior year period, stabilising at similar run rates to Q2, a reflection of cautious customer ordering patterns given the ongoing market uncertainty. As expected, operating margin increased during the period, driven by operational initiatives implemented in the past year and an effective pricing strategy. As a result operating profit was in line with the same period last year.

 

OrthoLite, prior to completion, has continued to perform well, delivering strong revenue growth and maintaining high operating margins. We remain excited about the potential of this high-quality, margin accretive business, which will enable us to expand into the growing open cell insole segment of the footwear market.

 

Performance Materials

 

Performance Materials continued to deliver an improving performance. As expected, there was a return to growth in the period with revenue increasing 4% compared to the prior year, driven by accelerated growth in two target adjacencies, safety fabrics and energy tapes, alongside market share gains in automotive thread which offset softness in Telecom end markets. Operating margins for the period were significantly ahead of prior year reflecting the benefit of operational improvements across the division.

 

Divisional Structure Change

 

On 30 October the Group announced that it has streamlined its organisation structure into two divisions: Apparel and Footwear, to reflect the transformation of the Group's profile following the exit from the North America Yarns business and the acquisition of OrthoLite. This change reduces internal complexity and aligns the divisions more closely with the underlying textile engineering and polymer science technologies. Coats' external reporting will align to this new structure with effect from the next financial year, the year ending December 2026.

 

Outlook

 

Given the resilient performance year to date, the Group's full year outlook remains unchanged, with trading performance in line with market expectations.

 

The acquisition of market-leading OrthoLite and the portfolio rationalisation actions now taken have improved the quality of the Group. As a result we are on track to continue our outperformance of underlying market growth supported by expansion into target adjacencies and deliver strong cash generation and further margin progression in the medium term. Our confidence is underpinned by our unrivalled global footprint, proprietary technology and sustainability led innovation.

 

The Group will release its Full Year 2025 results on 5 March 2026. An updated financial framework will be provided at the March results.

 

Enquiries

Coats Group plc (Investors)

Chris Dyett

 

FTI (Communications)

Nick Hasell

Victoria Hayns

 

Tel: +44 (0) 797 497 4690

Tel: +44 (0) 20 3727 1340

 

 

About Coats Group plc

Coats is a world-leading Tier 2 manufacturer and trusted partner for the apparel and footwear industries. We deliver essential materials, components, and software solutions that help our customers grow, compete and win.

 

With over 250 years of industry expertise, we're shaping the future of the apparel and footwear supply chain through insight-led innovation, impactful sustainability practices, and digital technologies that unlock better product quality, efficiency and performance.

 

Headquartered in the UK, Coats is a FTSE 250 company and a constituent of the FTSE4Good Index. In 2024, we generated $1.5 billion in revenue and employed 16,000 people worldwide - all united by a spirit of innovation, quality and service. Learn more at www.coats.com or follow us on LinkedIn.

 

Cautionary statement

Certain statements in this full year report are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKABQOBDDNDK
Date   Source Headline
25th Aug 20106:05 pmRNSHalf Year Results to 30 June 2010
18th Aug 20104:21 pmRNSHolding(s) in Company
19th Jul 20101:30 pmRNSHolding(s) in Company
5th Jul 20102:02 pmRNSNotification of Major Interest in Shares
30th Jun 20109:40 amRNSTotal Voting Rights
28th Jun 201011:42 amRNSDemerger of GPG Australia & Restructure of GPG plc
25th Jun 201010:11 amRNSDemerger of GPG Australia & Restructure of GPG plc
21st Jun 201011:46 amRNSChange of Director's Interests
16th Jun 20104:37 pmRNSHolding(s) in Company
16th Jun 20108:46 amRNSDemerger of GPG Australia & Restructure of GPG plc
14th Jun 20102:16 pmRNSNotification of Major Interests in Shares
7th Jun 201012:01 pmRNSDirector/PDMR Shareholding
4th Jun 20105:05 pmRNSIssue of Equity
1st Jun 20104:12 pmRNSHolding(s) in Company
28th May 201011:17 amRNSTotal Voting Rights
21st May 20105:41 pmRNSHolding(s) in Company
17th May 201012:08 pmRNSDirector/PDMR Shareholding
14th May 20105:00 pmRNSIssue of Equity
12th May 20102:22 pmRNSInterim Management Statement
7th May 20103:54 pmRNSDocument Viewing Facility
7th May 20103:10 pmRNSAGM Statement
6th May 20103:44 pmRNSDirector/PDMR Shareholding
30th Apr 201012:19 pmRNSHolding(s) in Company
29th Apr 20104:21 pmRNSAGM - Live Webcast
27th Apr 20102:53 pmRNSAnnual Information Update
31st Mar 20101:32 pmRNSTotal Voting Rights
31st Mar 201012:36 pmRNSTandou Limited
25th Mar 20106:24 pmRNSCirc re. Stock Events
25th Mar 20105:55 pmRNSAnnual Financial Report
18th Mar 20102:34 pmRNSRule 8.3- AH Medical Properties PLC
15th Mar 201010:46 amRNSCoats - 2009 Financial Results - Presentation
12th Mar 20102:54 pmRNSRule 8.3 - AH Medical Properties PLC
4th Mar 20103:24 pmRNSRule 8.3- AH Medical Properties PLC
1st Mar 20102:20 pmRNSChange of Registrar for Guinness Peat Group plc
26th Feb 20102:10 pmRNSFinal Results for Coats Group - Year End 31.12.09
26th Feb 20101:45 pmRNSFinal Results
19th Feb 201010:30 amRNSHolding(s) in Company
17th Feb 201010:48 amRNSHolding(s) in Company
9th Feb 201010:37 amRNSHolding(s) in Company
5th Feb 20101:13 pmRNSTandou Limited
15th Jan 201010:49 amRNSTandou Limited
30th Dec 20093:12 pmRNSHolding(s) in Company
16th Dec 20092:25 pmRNSChange to basis of ASX quotation of GPG shares
7th Dec 20095:14 pmRNSHolding(s) in Company
20th Nov 200912:21 pmRNSHolding(s) in Company
19th Nov 20094:37 pmRNSDirector/PDMR Shareholding
12th Nov 20091:16 pmRNSInterim Management Statement
30th Oct 200911:43 amRNSTotal Voting Rights
29th Oct 200910:37 amRNSTandou Limited
21st Oct 200910:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.